Pattathu Joseph, Michel Sebastian, Tengler Anja Ingrid, Mandilaras Guido, Jakob Andre, Dalla Pozza Robert, Haas Nikolaus A
Division of Pediatric Cardiology and Intensive care, University Hospital, Ludwigs-Maximilians University Munich, Munich, Germany.
Front Cardiovasc Med. 2023 Sep 8;10:1197985. doi: 10.3389/fcvm.2023.1197985. eCollection 2023.
We report the long-term effect after successfully implanting an 8 mm Atrial-flow-regulator (AFR) device in a 7-year-old girl with idiopathic pulmonary hypertension with persistent syncope under triple therapy with significant improvement after implantation and absence of any further syncope. Early Implantation of the AFR device (Occlutech, Germany) can be efficient and safe interventional therapy option for pulmonary arterial hypertension with a history of syncope.
我们报告了一名7岁特发性肺动脉高压女童成功植入8毫米心房血流调节器(AFR)装置后的长期效果。该女童在三联疗法下仍持续晕厥,植入AFR装置后症状显著改善,且未再出现晕厥。对于有晕厥病史的肺动脉高压患者,早期植入AFR装置(德国Occlutech公司生产)可能是一种有效且安全的介入治疗选择。